Russell Investments Group
INBX

Russell Investments Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Russell Investments Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-190,389
Closed -$6.66M – 3668
2024
Q1 		$6.66M Sell
190,389
-245,061
-56% -$8.94M 0.01% 1035
2023
Q4 		$16.5M Sell
435,450
-23,606
-5% -$506K 0.03% 577
2023
Q3 		$8.42M Buy
459,056
+33,515
+8% +$701K 0.02% 839
2023
Q2 		$11M Buy
425,541
+107,036
+34% +$2.5M 0.02% 733
2023
Q1 		$6.01M Sell
318,505
-1,040
-0.3% -$24.2K 0.01% 1025
2022
Q4 		$7.87M Sell
319,545
-21,059
-6% -$619K 0.02% 862
2022
Q3 		$6.11M Buy
340,604
+86,492
+34% +$1.56M 0.01% 958
2022
Q2 		$2.88M Buy
254,112
+89,337
+54% +$1.31M 0.01% 1391
2022
Q1 		$3.67M Sell
164,775
-93,806
-36% -$2.39M 0.01% 1318
2021
Q4 		$11.3M Buy
258,581
+24,664
+11% +$986K 0.02% 837
2021
Q3 		$7.79M Buy
233,917
+118,467
+103% +$3.6M 0.01% 1009
2021
Q2 		$3.18M Buy
+115,450
New +$2.4M 0.01% 1636

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Russell Investments Group's INBX Position: Q2 2024 in Review

Russell Investments Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 190,389 shares — an estimated $6.66M sold.

Russell Investments Group first reported a position in INBX in Q2 2021 and held it in 12 quarters. The position peaked at $16.5M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Russell Investments Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Russell Investments Group sold 190,389 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $6.66M.
  • Russell Investments Group first reported a position in Inhibrx, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Russell Investments Group's Inhibrx, Inc. Common Stock position peaked at $16.5M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Russell Investments Group's 13F filing for Q2 2024, filed 8 Aug 2024.